Pneumococcal vaccine - Millenium Biologix

Drug Profile

Pneumococcal vaccine - Millenium Biologix

Alternative Names: Streptococcus pneumoniae vaccine - Millenium Biologix

Latest Information Update: 02 Jun 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Millenium Biologix Corporation
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pneumococcal infections

Most Recent Events

  • 06 Dec 2004 Millenium Biologix has merged with Cytovax Biotechnologies to form Millenium Biologix Corporation
  • 16 Jun 2003 This programme is still in active development
  • 05 Nov 2001 Preclinical development for Pneumococcal infections in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top